A Phase II Study of Pemetrexed in Children With Recurrent Malignancies
收藏DataCite Commons2025-03-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004427/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To determine the response rate of pemetrexed given every 21 days for the treatment of children with relapsed or refractory osteosarcoma, Ewing's sarcoma/peripheral primitive neuroectodermal tumors (PNET), rhabdomyosarcoma, neuroblastoma, ependymoma, medulloblastoma/supratentorial PNET or non-brain stem high-grade glioma.
提供机构：
Vivli
创建时间：
2019-09-09
